MGAT1: Mannosyl (Alpha-1,3-)-Glycoprotein Beta-1,2-N-Acetylglucosaminyltransferase

Key enzyme in N-glycan biosynthesis and congenital disorders of glycosylation

Gene Information Card

Symbol MGAT1
Full Name Mannosyl (Alpha-1,3-)-Glycoprotein Beta-1,2-N-Acetylglucosaminyltransferase
Gene Type protein-coding
Chromosomal Location 5q35.3
NCBI Gene ID 4245 ncbi.nlm.nih.gov/gene/4245
Ensembl ID ENSG00000131473
UniProt ID P26572
OMIM ID 160995
HGNC ID 7044
Aliases GGNT1, GLCNAC-TI, GNT-I, MGAT

Description

MGAT1 encodes N-acetylglucosaminyltransferase I (GnT-I), a Golgi-resident enzyme that catalyzes the first committed step in the conversion of oligomannose to complex and hybrid N-glycans. This enzyme transfers N-acetylglucosamine from UDP-GlcNAc to the mannose residue of the Man5GlcNAc2 core structure. MGAT1 is essential for normal embryonic development and proper glycosylation of proteins. Mutations in MGAT1 cause congenital disorder of glycosylation type II (CDG II) and have been implicated in cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation type II (MGAT1-CDG) Loss-of-function mutations in MGAT1 impair N-glycan maturation, leading to multisystem developmental abnormalities. OMIM #160995; ClinVar
Colorectal cancer Altered MGAT1 expression affects N-glycan branching on cell surface receptors, influencing cell adhesion and metastasis. COSMIC; PubMed studies
Hepatocellular carcinoma Upregulation of MGAT1 correlates with increased complex N-glycans and poor prognosis. COSMIC; PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 9.8 Medium
Brain 7.2 Low
Lung 6.5 Low
Colon 11.3 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression
HepG2 13.8 High expression
HeLa 10.1 Medium expression
A549 8.5 Medium expression
K562 4.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.661G>A (p.Gly221Arg) Missense Rare Loss of enzymatic activity; associated with CDG II
c.1063C>T (p.Arg355Trp) Missense Rare Reduced GnT-I activity; developmental delay
c.1201_1202del (p.Leu401fs) Frameshift Very rare Complete loss of function; severe CDG phenotype
Mutation functional classification

Loss of Function (LOF)

Most reported MGAT1 mutations are loss-of-function, leading to reduced or absent GnT-I activity and defective N-glycan processing.

Gain of Function (GOF)

No gain-of-function mutations have been documented in MGAT1.

Dominant Negative (DN)

No dominant-negative mutations have been reported for MGAT1.

Pathways

N-Glycan biosynthesis (Reactome: R-HSA-446203)
Biosynthesis of the N-glycan precursor (KEGG: hsa00510)
Protein glycosylation (UniProt: P26572)

Protein Summary

The MGAT1 protein (GnT-I) is a type II transmembrane glycoprotein localized to the Golgi apparatus. It consists of a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain facing the Golgi lumen. GnT-I is essential for the synthesis of hybrid and complex N-glycans by adding a GlcNAc residue to the Man5GlcNAc2 core. The enzyme requires manganese ions as a cofactor. Structural studies reveal a GT-A fold with a conserved DXD motif critical for UDP-GlcNAc binding.

Related Products

Product name Cat.No. Species Gene ID
MGAT1 Knockout HEK293 Cell Line EDJ-KQ1872 Human 4245 Details Get a Quote
MGAT1 Knockout A-549 Cell Line EDJ-KQ23111 Human 4245 Details Get a Quote
MGAT1 Knockout HCT 116 Cell Line EDJ-KQ23113 Human 4245 Details Get a Quote
MGAT1 Knockout HeLa Cell Line EDJ-KQ23114 Human 4245 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: